Insmed (INSM) Misses Q3 EPS by 7c ; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Wall St set for lower open as AI jitters rekindle, oil gains
- Oil jumps on escalating Middle East conflict
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- JPMorgan says AI stock selling may be nearing its limit as positioning resets
Tweet
Share
E-mailGet Alerts INSM Hot Sheet
Price: $94.04 --0%
EPS Growth %: +77.7%
Financial Fact:
Investment income: 138K
Today's EPS Names:
SICP, MNSB, CFFI, More
EPS Growth %: +77.7%
Financial Fact:
Investment income: 138K
Today's EPS Names:
SICP, MNSB, CFFI, More
Join SI Premium – FREE
Insmed (NASDAQ: INSM) reported Q3 EPS of ($1.27), $0.07 worse than the analyst estimate of ($1.20). Revenue for the quarter came in at $93.42 million versus the consensus estimate of $93.35 million.
GUIDANCE:
Insmed sees FY2024 revenue of $340-360 million, versus the consensus of $357.1 million.
For earnings history and earnings-related data on Insmed (INSM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SK Hynix could join the Nasdaq 100 if it expands its ADR float: Goldman
- Norfolk Southern (NSC) Tops Q3 EPS by 14c
- NVR, Inc. (NVR) Misses Q3 EPS by 1332c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
